drugset / Trial / NCT03300518

Effectiveness of Estradiol Valerate Pretreatment in Antagonist Protocol for Poor Ovarian Response Patient

NCT03300518

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of study is to assess the efficacy of add-on estrogen pretreatment in GnRH antagonist protocol on oocyte retrieval as compared with GnRH antagonist protocol for patients with poor ovarian response Add-on estrogen pretreatment protocol is superior to none pretreatment GnRH antagonist protocol for the number of oocytes retrieval

Timeline

Start
2017-11-15
Primary completion
2021-06-18
Completion
2021-08-18

Drugs

EvaluationDrugModalityDoseRoute
Subject estradiol valerate Unknown 2 mg Oral
Background Follitropin beta Protein / enzyme biologic 300 iu Subcutaneous
Background Ganirelix Protein / enzyme biologic 0.25 mg
Background hCG Unknown 10000 iu

Indications